Researchers identify a "target" in the brain—such as a specific receptor—and design molecules to interact with it.
Psychiatric drug development is notoriously difficult, with only about successfully transitioning from Phase I to approval.
The FDA examines all data to determine if the drug's benefits outweigh its risks. Download File Drug Development in Psychiatry.sa...
The development of psychiatric medications typically follows five critical stages:
Post-market monitoring once the drug is available to the public. Researchers identify a "target" in the brain—such as
Safety and dosage testing in a small group of healthy volunteers.
The drug development process in psychiatry is a multi-decade journey characterized by high scientific complexity, significant regulatory hurdles, and a historically low success rate compared to other medical fields. Before human testing, drugs undergo in vitro (test
Before human testing, drugs undergo in vitro (test tube) and in vivo (animal) testing to assess basic safety and how the drug is metabolized. Clinical Research (The 4 Phases):